To determine whether MYC or PTEN status added information to preoperative variables commonly used in prostate cancer risk assessment algorithms, the ROC curves were assessed for the presence of non–organ-confined disease at radical prostatectomy. This evidence concerns the gene MYC and prostate carcinoma.